Overview

Epidemiological Study to Evaluate Personality Disorders in Prison Populations in Treatment for Hepatitis C

Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
Primary objective: Evaluate the prevalence of personality disorders in patients starting treatment for hepatitis C in the prison and determine their influence on the evolution of the disease.
Details
Lead Sponsor:
Grupo de Enfermedades Infecciosas de la Sociedad EspaƱola de Sanidad Penitenciaria
Treatments:
Interferon-alpha
Peginterferon alfa-2a
Ribavirin